Clinical Trials

Keywords/SWOG Study Number

Area of Research

Accrual Status

Any

Open

Closed

Limit to SWOG Trials

All Trials

SWOG Trials Only

Show only published studies

Study Type

Treatment

Study Chair

Participating Institution

Phase

Cancer Control Subcommittee

Study Sponsor

FDA Registration Trial

Uses PRO Forms

1047 Results

View

Open

Phase

Accrual

0%

SWOG Clinical Trial Number

S2504

A Randomized Phase III Study of PIRtobrutinib plus R-CHOP vs. R-CHOP for Patients with Previously UntreateD RIchter TrAnsforMation (RT) (pirAMID)

Status Notes

Study is active as of 06/01/2026.

Research Committee(s)

Leukemia

Lymphoma

Activated

06-01-2026

ClinicalTrials.gov Registry Number

07220187

Open

Phase

Accrual

0%

SWOG Clinical Trial Number

S2424CD

A Randomized Controlled Trial of an Intervention called Algorithm-Enabled Patients Activated in Cancer Care through Teams (A-PACT) to Improve Goals of Care Communication for People with Cancer

Status Notes

Activation 06/01/2026

Research Committee(s)

Cancer Care Delivery

Activated

06-01-2026

ClinicalTrials.gov Registry Number

07278739

Open

Phase

Accrual

0%

SWOG Clinical Trial Number

S2419

Phase II/III Double Blinded Trial of Immune-Based Therapy with a Live Biotherapeutic MO-03, or Placebo for Frontline Therapy of Advanced Clear Cell Renal Cell Carcinoma (BioFront Trial)

Status Notes

Active as of 4/22/2026.

Research Committee(s)

Genitourinary Cancer

Activated

04-22-2026

ClinicalTrials.gov Registry Number

NCT07383441

Open

Phase

Accrual

8%

SWOG Clinical Trial Number

SN2426

A Randomized Phase II Study of Amivantamab (JNJ-61186372) and hyaluronidase (rHuPH20) versus Cetuximab in Immunocompromised Participants with Recurrent Inoperable or Metastatic Cutaneous Squamous Cell Carcinoma

Research Committee(s)

Early Therapeutics & Rare Cancers

Sarcoma

Activated

01-28-2026

ClinicalTrials.gov Registry Number

07042295

Open

Phase

Accrual

1%

SWOG Clinical Trial Number

S2433

Randomized Phase III Study of Second-Line Chemotherapy with or without Panitumumab for Locally Advanced or Metastatic KRAS Wild Type Pancreatic Adenocarcinoma

Research Committee(s)

Gastrointestinal Cancer

Activated

12-26-2025

ClinicalTrials.gov Registry Number

NCT06998940

Open

Phase

Accrual

6%

SWOG Clinical Trial Number

21CTP.HN01

Phase II Study of Amivantamab carboPlatin and pacliTaxel in recurrent metastatic Head and Neck cancer (CAPT-HN) Study Synopsis

Status Notes

Activation - Effective 09/15/2025

SWOG Clinical Trials Partinerships
https://www.swogctp.org/trials/21ctphn01/

Research Committee(s)

SWOG CTP

Head and Neck Cancer

Activated

09-15-2025

ClinicalTrials.gov Registry Number

07062354